Holdings of Amplify Weight Loss Drug & Treatment ETF
Amplify ETF Trust · 20 declared positions · as of Mar 31, 2026
Original filing · Net assets 4.2M $ · Ten largest lines: 69.9 % of the equity sleeve
Sector breakdown
- Health care 62.5 %
- Unattributed 37.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 69.9 %
- HKD 11.2 %
- JPY 11.0 %
- CHF 4.7 %
- DKK 1.8 %
- KRW 1.3 %
The quoted currency of each line, as declared.
Country breakdown
- US 52.5 %
- DK 14.3 %
- HK 11.2 %
- JP 11.0 %
- GB 4.9 %
- CH 4.7 %
- KR 1.3 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 10 | 2.1M $ | 52.55 % |
| DK | 2 | 565.6K $ | 14.31 % |
| HK | 3 | 444K $ | 11.23 % |
| JP | 2 | 434.3K $ | 10.99 % |
| GB | 1 | 193.3K $ | 4.89 % |
| CH | 1 | 185.2K $ | 4.69 % |
| KR | 1 | 53.1K $ | 1.34 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Novo Nordisk A/S | 13,431 | 493.6K $ | 11.89 % |
| Eli Lilly & Co | 522 | 480.1K $ | 11.56 % |
| Regeneron Pharmaceuticals, Inc. | 364 | 281.2K $ | 6.77 % |
| Amgen Inc | 740 | 260.4K $ | 6.27 % |
| Chugai Pharmaceutical Co Ltd | 4,600 | 249K $ | 6.00 % |
| CSPC Pharmaceutical Group Ltd | 180,000 | 208.9K $ | 5.03 % |
| Arrowhead Pharmaceuticals Inc | 3,287 | 206.1K $ | 4.96 % |
| AbbVie Inc | 907 | 197.3K $ | 4.75 % |
| AstraZeneca PLC | 980 | 193.3K $ | 4.66 % |
| Pfizer Inc | 6,828 | 191.7K $ | 4.62 % |
| Merck & Co Inc | 1,546 | 186K $ | 4.48 % |
| Shionogi & Co Ltd | 8,500 | 185.3K $ | 4.46 % |
| Roche Holding AG | 473 | 185.2K $ | 4.46 % |
| Innovent Biologics Inc | 17,000 | 184.1K $ | 4.43 % |
| Scholar Rock Holding Corp | 2,005 | 98.6K $ | 2.37 % |
| Viking Therapeutics Inc | 2,818 | 91.7K $ | 2.21 % |
| Structure Therapeutics Inc | 1,738 | 83.8K $ | 2.02 % |
| Zealand Pharma A/S | 1,584 | 72.1K $ | 1.74 % |
| Hanmi Pharm Co Ltd | 158 | 53.1K $ | 1.28 % |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 6,200 | 51K $ | 1.23 % |